People waste non-alcoholic in semaglutide
Shutterstock / David mg
Semagluturo seems to help people who really addictive alcohol Reduce your intake, according to the first clinical test of drugs.
Including Wegoy and Ozempic, Semaglutide, Semaglutide, imitates the hormone called Glucagon’s Peptide-1 (GLP-1). Therefore, the GLP-1 recipient is agonist. The drug was first used to treat type 2 diabetes, but because it reduces hunger, Wegoy now has a degree in weight loss In eight countries. Semaglutide has also helped with extraordinary help Number of medical conditions.
In terms of alcohol use, 2024 people injected 2024 people injected Ozempic or Wegoy lower risk of alcoholism. As a result, he showed correlation showing correlation rather than causation.
But now, Christian Hendershot At the University of California and his colleagues have formed the first random test of the clinical impact of the Semaglutide effect, a type of study that can bend the causation.
Their trial had been diagnosed with 48 people in the United States, 34 of which were women and were 14 men. Halves received injections of low dose semagluturus for nine weeks and the rest plawho injections.
Semagluturo was consumed less drinks for each drinking session and reduced alcohol-free desires compared to placebo.
“We had no evidence of important concerns about medications in this population and we were generally found in different drinking results, which people consumed the amount of alcohol,” says Hendershot.
“The results are hopeful,” he says Rong xu Western Reserve University School of Medicine Ohio. “Despite the small size of the sample, this random clinical test is a therapeutic potential of semeagluturum to treat alcohol use”.
Ziyad al-Aly At Washington University in St. Louis, Missouri, examination “GLP-1RAS (adds other evidence that agonists of GLP-1 recipients can be helpful.”
There are greater studies to confirm the work, and whether people increase the drinking questions, if semeagluturus disappears and what the long-term effects can be, especially concerns about the loss Bone and muscle mass.
The initial investigation should be treated as hopeful evidence, says Hendershot, but more research is needed. People would not take semagluturous for alcohol problems, he says.
“This is like this and people are excited, but we have the use of alcohol use medications, so that more research is done, people now continue to follow and accept the medication there,” says Hendershot.
Themes:
